These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


384 related items for PubMed ID: 16159936

  • 1. Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
    Feelders RA, Bidlingmaier M, Strasburger CJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW, van der Lely AJ, de Herder WW.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6480-9. PubMed ID: 16159936
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 3. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC, Rossi A, Martinelli CE, Machado HR, Moreira AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P, Hildebrandt G, Schaeffer HJ, Schönau E, Klug N.
    Exp Clin Endocrinol Diabetes; 1998 Jul; 106(2):130-4. PubMed ID: 9628244
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 6. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O, Beauregard C, Hardy J.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 8. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
    Carmichael JD, Bonert VS, Mirocha JM, Melmed S.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
    [Abstract] [Full Text] [Related]

  • 9. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
    Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
    [Abstract] [Full Text] [Related]

  • 10. Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria.
    Ronchi CL, Varca V, Giavoli C, Epaminonda P, Beck-Peccoz P, Spada A, Arosio M.
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1377-82. PubMed ID: 15585548
    [Abstract] [Full Text] [Related]

  • 11. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Esposito F, Cappabianca P, Lombardi G.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [Abstract] [Full Text] [Related]

  • 12. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernández I, Ovalle A, Mendoza V.
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [Abstract] [Full Text] [Related]

  • 13. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
    Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V.
    Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
    [Abstract] [Full Text] [Related]

  • 14. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P, Zwimpfer C, Zapf J, Schmid C.
    Acta Obstet Gynecol Scand; 2006 May; 85(8):900-5. PubMed ID: 16862465
    [Abstract] [Full Text] [Related]

  • 15. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M.
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [Abstract] [Full Text] [Related]

  • 16. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC.
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [Abstract] [Full Text] [Related]

  • 17. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
    Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
    [Abstract] [Full Text] [Related]

  • 18. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR, van Dulken H, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly.
    Hernandez I, Soderlund D, Espinosa-de-los-Monteros AL, Ochoa R, Zarate A, Mercado M.
    J Neurosurg; 1999 Apr; 90(4):647-50. PubMed ID: 10193608
    [Abstract] [Full Text] [Related]

  • 20. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
    Kristof RA, Neuloh G, Redel L, Klingmüller D, Schramm J.
    J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.